Clinical Trial Update: Long-Term Study of TS-142 in Patients with Insomnia [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of TS-142 in patients with insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• TS-142

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Patients with Insomnia | Phase 3 | Status: COMPLETED